menu
    • menu

    Company profile for Eisai Inc

    NEW Drugs in Dev: 68
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Eisai Inc., human health care (hhc) is our goal. We give our first thought to patients and their families, and help to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., the company has a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs. Eisai is a ...
    At Eisai Inc., human health care (hhc) is our goal. We give our first thought to patients and their families, and help to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., the company has a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs. Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Eisai IncUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    200 Metro Blvd, Nutley, NJ 07110
    Telephone
    Telephone
    +1 2016921100
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://us.eisai.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/eisai/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/eisaius?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Eisai, CaringKind Launch Alzheimer's Nutrition Initiative
    Eisai, CaringKind Launch Alzheimer's Nutrition Initiative

    01 Jun 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/eisai-and-caringkind-launch-new-initiative-to-address-mealtime-and-nutrition-needs-for-people-living-with-alzheimers-disease-and-related-dementias-302785002.html

    PR NEWSWIRE
    01 Jun 2026
    Share Share
    Eisai Targets JPY 1 Trillion Revenue by 2028
    Eisai Targets JPY 1 Trillion Revenue by 2028

    26 May 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7477231

    FIRSTWORD PHARMA
    26 May 2026
    Share Share
    Eisai Presents Leqembi Sales Simulation at Investor Relations Day
    Eisai Presents Leqembi Sales Simulation at Investor Relations Day

    26 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/bioarctics-partner-eisai-presents-sales-simulation-of-potential-future-sales-of-leqembi-at-its-investor-relations-day-302781008.html

    PR NEWSWIRE
    26 May 2026
    Share Share
    Eisai Deepens LENVIMA Evidence Across Indications at ASCO 2026
    Eisai Deepens LENVIMA Evidence Across Indications at ASCO 2026

    20 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/eisai-deepens-body-of-clinical-evidence-for-lenvima-lenvatinib-across-established-indications-at-asco-2026-302776712.html

    PR NEWSWIRE
    20 May 2026
    Share Share
    Eisai Projects Leqembi® Revenue of JPY 143.5B for FY2026
    Eisai Projects Leqembi® Revenue of JPY 143.5B for FY2026

    15 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/eisai-projects-leqembi-revenue-to-total-jpy-143-5-billion-for-fiscal-year-2026-april-2026--march-2027-302773356.html

    PR NEWSWIRE
    15 May 2026
    Share Share
    Biogen, Eisai Face 3-Month Delay on SubQ Alzheimer's Therapy
    Biogen, Eisai Face 3-Month Delay on SubQ Alzheimer's Therapy

    08 May 2026

    // BIOSPACE

    https://www.biospace.com/fda/biogen-eisai-hit-with-3-month-delay-for-starting-subq-alzheimers-therapy

    BIOSPACE
    08 May 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Eisai Switzerland and get a quotation

    Eisai Switzerland is a supplier offers 3 products (APIs, Excipients or Intermediates).

    Find MOH040 bulk with DMF offered by Eisai Switzerland

    Find INTERLEUKIN-2 DIPHTHERIA TOXIN FUSION PROTEIN (DAB 389 IL-2) bulk offered by Eisai Switzerland

    Find Eperisone Hydrochloride bulk offered by Eisai Switzerland

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search